Category: Featured Content
-
Freeman Gold (FMAN.C) 1st 3,000 meters of Idaho drilling reveals visible gold
The mineralization at the Lemhi Project consists of shallow, near surface primarily oxide gold mineralization that has seen over 355 drill holes but remains open at depth and along strike.
-
Sixth Wave (SIXW.C) gets $250,000 Covid-19 development money from Nova Scotia
SIXW is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs).
-
Brigadier Gold (BRG.V) sees rich veins extending in early results of new drilling program
If you’ve ever watched the litany of gold mining programs on cable TV’s reality TV channels, you’ve seen folks jumping up and down like they have a weasel in their pants whenever they hit enough gold to cast a teenager’s valentine pendant. “OMG IT’S A BEAUTY!” will cry some rough around the edges Australian with…
-
PredictMedix (PMED.C) hits some supply chain snags with their COVID detectors, but everything’s all right
Every company goes through growing pains. These are generally small bumps on the road that get in the way of stiff, steady growth, and the way the company meets these challenges is really the difference between a flash in the pan and a company that maintains a steady burn that cuts through the generations. It…
-
Revive Therapeutics (RVV.C) to have 10 clinical COVID-19 FDA trial sites by end of year
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks laughed uproariously at the thought that a three time loser might be relevant in 2020. Having missed on an earlier pharma focus, and come to the cannabis party a little…
-
FansUnite (FANS.C) RNG games get wider distribution in Europe
The arrangements with game aggregators are on a revenue share basis, Askott Games will receive a share of the net gaming revenue every time one of their games is played.
-
Perimeter Medical Imaging AI (PINK.V) isn’t messing about: Let’s make breast cancer treatment better – and profitable!
In the North American biotech space, you hear a lot of ‘promise’ from companies and their teams. Lots of ‘we’re going to take this to trial’, and a lot of ‘billion dollar industry’ talk. Lots of early stage bets, a little over-hype perhaps. For the most part, you’re being asked to invest in technologies that…